NCT03110835View on ClinicalTrials.gov

Low-dose Radioiodine Ablation in Graves' Disease

CompletedOBSERVATIONAL

Enrollment

12

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

March 28, 2017

Study Completion Date

March 28, 2017

Conditions

Thyroid Diseases

Interventions

RADIATION

Radioiodine

Administration of radioiodine

All Listed Sponsors

lead

University of Pisa

OTHER

NCT03110835 - Low-dose Radioiodine Ablation in Graves' Disease | Biotech Hunter | Biotech Hunter